US 12070628
Low energy immune priming for treating cancer and metastasis
granted A61KA61K45/06A61K49/223
Quick answer
US patent 12070628 (Low energy immune priming for treating cancer and metastasis) held by Montefiore Medical Center expires Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Montefiore Medical Center
- Grant date
- Tue Aug 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 32
- CPC classes
- A61K, A61K45/06, A61K49/223